Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New therapy could treat poor blood circulation caused by peripheral artery disease

09.03.2016

An injectable gel was tested in a rat model of critical limb ischemia

Bioengineers and physicians at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs and leads to an estimated 230,000 amputations every year in North America and Europe alone to prevent the spread of infection and tissue death. The new therapy could prevent or limit amputations for a condition that affects more than 27 million people and is a manifestation of advanced peripheral arterial disease.


Tissue from the skeletal muscle of pigs is spun in detergent until only the fibrous extracellular matrix remains.

Credit: Jacobs School of Engineering/UC San Diego

The therapy consists of injecting in the affected area a gel derived from the natural scaffolding, or extracellular matrix, in skeletal muscle tissue. The team tested the procedure in a rat model of the disease and found that it promotes muscle remodeling and improves blood flow. They published their findings recently in the inaugural issue of the Journal of the American College of Cardiology: Basic to Translational Science.

"This is a unique approach that not only helps repair the damaged vascular system, but also helps restore muscle tissue," said Karen Christman, a professor of bioengineering at the Jacobs School of Engineering and the Sanford Consortium for Regenerative Medicine at UC San Diego and the paper's senior author.

"Avoiding or limiting extent of amputations is a huge benefit for patients," said Dr. Ehtisham Mahmud, chief of cardiovascular medicine at the Sulpizio Cardiovascular Center at UC San Diego and a study co-investigator.

Christman and Mahmud partnered to make sure the study's design would eventually help patients when the therapy was ready for the clinic--a step that should take about two years. "This is what makes UC San Diego unique," said Mahmud. "We are bringing together engineering and medicine and demonstrating the translational implications of preclinical research."

As far as researchers know, no one had tried to use an injectable material by itself to treat both the low blood flow and weakened skeletal muscle in critical limb ischemia.

Peripheral arterial disease and critical limb ischemia

Peripheral arterial disease patients suffer from poor circulation in their limbs, which can lead to critical tissue damage. The condition is associated with atherosclerosis in old age, diabetes and smoking. It affects men and women equally. In the most extreme form, called critical limb ischemia, a severe obstruction of arteries in the limbs reduces blood flow to hands, feet and legs. Some of Mahmud's patients experience severe pain in their limbs. Some already suffer from tissue necrosis, or amputations. Others suffer from wounds that won't heal and get infected because they lack proper blood supply.

For these patients, traditional surgery or endovascular procedures can often reestablish normal blood flow. But when these interventions fail or aren't possible, limited options remain. So far, potential therapies for these patients, including using growth factor, gene or cell therapy, have proven problematic and costly. Amputations end up being a common option for treatment in severe cases of critical limb ischemia, Mahmud said.

Injectable gel therapy

Christman's team had already shown that injection of a gel derived from cardiac muscle tissue extracted from pigs could help repair the heart after a heart attack. The tissue is stripped of cells, leaving behind a scaffold of the extracellular matrix from cardiac muscle, which acts a regenerative environment where cells can grow again.

Using this same concept, Christman and her team now are turning their attention to peripheral artery disease and critical limb ischemia. They developed a material that was derived from the skeletal muscle of pigs to treat damaged skeletal muscle in these patients. Researchers injected the gel into the affected area in a rat model of the disease seven days post-surgery and monitored blood flow in the rats' limbs up to 35 days after injection.

Researchers found that the hydrogel increased the diameter of the rats' larger blood vessels, called arterioles. The increased diameter led to improved blood flow in the limbs. By day 35, the size and structure of muscle fibers in the rats treated with the hydrogel was comparable to that in healthy rats.

The gel, which forms a fibrous scaffold upon injection, also attracted muscle stem cells to the affected area. Gene expression analysis showed that inflammatory response and cell death decreased while blood vessel and muscle development pathways increased in rats injected with the gel.

Next steps include looking at other disease models in animals and refining preclinical safety protocols and quality control for manufacturing. Ventrix, a startup cofounded by Christman, partially licensed the technology from UC San Diego for clinical applications.

###

Jessica L. Ungerleider and Todd D. Johnson from the Department of Bioengineering at the University of California, San Diego, were co-first authors of the study. Other authors included UC San Diego bioengineers Melissa J. Hernandez, Dean I. Elhag and Rebecca L. Braden; Monika Dzieciatkowska and Kirk C. Hansen from the Department of Biochemistry and Molecular Genetics at the School of Medicine at the University of Colorado, Aurora; and Kent G. Osborn from the Animal Care Program at UC San Diego.

Funding was provided in part by the Heart, Lung and Blood Institute at the National Institutes of Health and the American Heart Association.

Media Contact

Ioana Patringenaru
ipatrin@eng.ucsd.edu
858-822-0899

 @UCSanDiego

http://www.ucsd.edu 

Ioana Patringenaru | EurekAlert!

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>